Skip to main content
Main navigation
Home
About pCPA
Who We Are
Governance
FAQs
Negotiations
Recent Updates
Forms and Publications
Brand Name Drugs
Negotiations Status
Negotiation Process
Generic Drugs
Biologics/Biosimilars
Contact Us
EN
FR
Inclunox (enoxaparin)
pCPA File Number:
21360
Negotiation Status:
Concluded with an LOI
Indication(s):
Deep vein thrombosis (treatment and prevention)
Sponsor/Manufacturer:
Sandoz Canada Inc.
CADTH Project Number:
Not Applicable
pCPA Engagement Letter Issued:
2021-01-28
Negotiation Process Concluded:
2021-04-15